Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

283 ARTÍCULOS , VIENDO DEL 76 AL 90

[Premature immunosenescence: a pathogenetic factor in Alzheimer's disease?]

Richartz-Salzburger E, Stransky E, Laske C, Köhler N.

Nervenarzt. 2010 Jul;81(7):837-43. doi: 10.1007/s00115-009-2918-7.

100th anniversary of Perusini's second case: patient RM and his kindred

Braun B, Stadlober-Degwerth M, Hajak G, Klünemann HH.

Am J Alzheimers Dis Other Demen. 2010 May;25(3):189-92. doi: 10.1177/1533317509356689. Epub 2010 Apr 14.

Cognition and function in Alzheimer's disease: identifying the transitions from moderate to severe disease

Schwam E, Xu Y.

Dement Geriatr Cogn Disord. 2010;29(4):309-16. doi: 10.1159/000269837. Epub 2010 Apr 16.

Physical activity and implications on well-being in mild Alzheimer's disease: A qualitative case study on two men with dementia and their spouses

Cedervall Y, Aberg AC.

Physiother Theory Pract. 2010 May;26(4):226-39. doi: 10.3109/09593980903423012.

Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease

Dong J, Revilla-Sanchez R, Moss S, Haydon PG.

Neuropharmacology. 2010 Sep-Oct;59(4-5):268-75. doi: 10.1016/j.neuropharm.2010.04.007. Epub 2010 Apr 14.

Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics

Duce JA, Bush AI.

Prog Neurobiol. 2010 Sep;92(1):1-18. doi: 10.1016/j.pneurobio.2010.04.003. Epub 2010 May 2.

Perspective on the Alzheimer's disease neuroimaging initiative: progress report and future plans

Khachaturian ZS.

Alzheimers Dement. 2010 May;6(3):199-201. doi: 10.1016/j.jalz.2010.04.002.

The Alzheimer's disease neuroimaging initiative: progress report and future plans

Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):202-11.e7. doi: 10.1016/j.jalz.2010.03.007.

Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative

Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):212-20. doi: 10.1016/j.jalz.2010.03.004.

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006.

Diagnosis of Alzheimer's disease from EEG signals: where are we standing?

Dauwels J, Vialatte F, Cichocki A.

Curr Alzheimer Res. 2010 Sep;7(6):487-505. doi: 10.2174/156720510792231720.

ECT treatment for two cases of dementia-related aggressive behavior

Wu Q, Prentice G, Campbell JJ.

J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):E10-11. doi: 10.1176/jnp.2010.22.2.247.e10.

Early-onset Alzheimer disease: the contribution of neuroimaging for the diagnosis

Pedrosa R, Teixeira-Sousa V, Fonseca S, Bastos-Leite AJ.

Psychiatry Res. 2010 Jun 30;182(3):287-8. doi: 10.1016/j.pscychresns.2010.04.009. Epub 2010 May 21.

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ.

J Nucl Med. 2010 Jun;51(6):913-20. doi: 10.2967/jnumed.109.069088.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias